InvestorsHub Logo
Post# of 251707
Next 10
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

Re: Rocky3 post# 186919

Tuesday, 02/03/2015 4:27:02 PM

Tuesday, February 03, 2015 4:27:02 PM

Post# of 251707
GILD’s 4Q14 HCV sales:

http://finance.yahoo.com/news/gilead-sciences-announces-fourth-quarter-210500475.html

Harvoni $2.11B (95% US)
Sovaldi $1.73B (68% US)
===
Total HCV sales $3.84B (83% US)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.